• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors.

作者信息

Lai Eric, Lee Timothy, Lee Claire, Schechet Sidney A

机构信息

Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, USA.

Ophthalmology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.

出版信息

BMJ Open Ophthalmol. 2024 Aug 29;9(1):e001854. doi: 10.1136/bmjophth-2024-001854.

DOI:10.1136/bmjophth-2024-001854
PMID:39209742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367370/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fee/11367370/fb32589626bb/bmjophth-9-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fee/11367370/fb32589626bb/bmjophth-9-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fee/11367370/fb32589626bb/bmjophth-9-1-g001.jpg

相似文献

1
New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors.地理性萎缩治疗的新视野：围绕补体抑制剂的热情与谨慎
BMJ Open Ophthalmol. 2024 Aug 29;9(1):e001854. doi: 10.1136/bmjophth-2024-001854.
2
Complement Inhibitors for the Treatment of Geographic Atrophy.用于治疗地图状萎缩的补体抑制剂
Ophthalmic Surg Lasers Imaging Retina. 2023 Feb;54(2):66-70. doi: 10.3928/23258160-20230106-01. Epub 2023 Feb 1.
3
Complement inhibitors for the treatment of geographic atrophy.用于治疗地图样萎缩的补体抑制剂。
Lancet. 2023 Oct 21;402(10411):1396-1398. doi: 10.1016/S0140-6736(23)01844-5.
4
New Treatment Modalities for Geographic Atrophy.地图样萎缩的新治疗方式
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):508-513. doi: 10.22608/APO.2017262. Epub 2017 Sep 14.
5
Complement Inhibitors in Geographic Atrophy:: Balancing Risks and Rewards.地图样萎缩中的补体抑制剂：权衡风险与收益
Retina. 2024 Sep 1;44(9S):S1-S8. doi: 10.1097/01.iae.0001050616.54362.fc.
6
Latest Developments in the Management of AMD.年龄相关性黄斑变性治疗的最新进展
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):477-478. doi: 10.22608/APO.2017480.
7
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.C5 抑制剂阿伐西普 Pegol 治疗年龄相关性黄斑变性相关地图状萎缩：一项随机关键性 2/3 期试验。
Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1.
8
[Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice].[地理性萎缩（GA）的补体抑制治疗：临床实践中的功能和形态学疗效及相关生物标志物]
Ophthalmologie. 2024 Jun;121(6):476-481. doi: 10.1007/s00347-024-02039-z. Epub 2024 Apr 30.
9
[Therapy approaches for geographic atrophy].[地图样萎缩的治疗方法]
Ophthalmologe. 2010 Nov;107(11):1016-9. doi: 10.1007/s00347-010-2160-5.
10
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.培塞利珠单抗治疗与年龄相关的黄斑变性相关性地图状萎缩的 2 期随机临床试验
Ophthalmology. 2020 Feb;127(2):186-195. doi: 10.1016/j.ophtha.2019.07.011. Epub 2019 Jul 16.

引用本文的文献

1
Investigating Macular Tissue Integrity Index as a Novel Biomarker in Geographic Atrophy.研究黄斑组织完整性指数作为地图状萎缩的一种新型生物标志物。
Ophthalmol Sci. 2025 Jun 30;5(6):100871. doi: 10.1016/j.xops.2025.100871. eCollection 2025 Nov-Dec.
2
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration.随着进展至晚期年龄相关性黄斑变性的时间推移，系统性补体激活的动态风险
JAMA Ophthalmol. 2025 Jun 12. doi: 10.1001/jamaophthalmol.2025.1608.
3
Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.

本文引用的文献

1
Health Span vs Lifespan in Geographic Atrophy.地理性萎缩中的健康寿命与寿命
JAMA Ophthalmol. 2024 Jun 1;142(6):558-559. doi: 10.1001/jamaophthalmol.2024.1209.
2
Deep Learning-Based Prediction of Individual Geographic Atrophy Progression from a Single Baseline OCT.基于深度学习从单次基线光学相干断层扫描预测个体地理萎缩进展
Ophthalmol Sci. 2024 Jan 17;4(4):100466. doi: 10.1016/j.xops.2024.100466. eCollection 2024 Jul-Aug.
3
Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.
2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂与二肽基肽酶-4抑制剂的使用及年龄相关性黄斑变性：一项多国队列研究
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):58. doi: 10.1167/iovs.66.4.58.
玻璃体内注射培西加可兰后的视网膜血管炎：来自美国视网膜专家协会治疗研究与安全（ReST）委员会的报告
J Vitreoretin Dis. 2023 Dec 21;8(1):9-20. doi: 10.1177/24741264231220224. eCollection 2024 Jan-Feb.
4
Treating patients with geographic atrophy: are we there yet?治疗地图状萎缩患者：我们做到了吗？
Int J Retina Vitreous. 2023 Nov 20;9(1):72. doi: 10.1186/s40942-023-00493-6.
5
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.培格司他单抗治疗与年龄相关的黄斑变性（OAKS 和 DERBY）相关的地图状萎缩：两项多中心、随机、双盲、假对照、3 期临床试验。
Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9.
6
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.阿伐西普妥单抗治疗地图样萎缩患者的疗效和安全性（GATHER2）：一项随机、双盲、3期试验的12个月结果
Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8.
7
A Cost-Effectiveness Analysis of Pegcetacoplan for the Treatment of Geographic Atrophy.佩格司他单抗治疗地图状萎缩的成本效果分析。
Ophthalmol Retina. 2024 Jan;8(1):25-31. doi: 10.1016/j.oret.2023.08.003. Epub 2023 Aug 11.
8
COMPLEMENT INHIBITION FOR GEOGRAPHIC ATROPHY: Review of Salient Functional Outcomes and Perspective.补体抑制治疗地图状萎缩：主要功能结局回顾与展望。
Retina. 2023 Jul 1;43(7):1064-1069. doi: 10.1097/IAE.0000000000003796.
9
Complement Inhibitors for the Treatment of Geographic Atrophy.用于治疗地图状萎缩的补体抑制剂
Ophthalmic Surg Lasers Imaging Retina. 2023 Feb;54(2):66-70. doi: 10.3928/23258160-20230106-01. Epub 2023 Feb 1.
10
Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis.非渗出性年龄相关性黄斑变性的全身补体激活谱：一项荟萃分析
J Clin Med. 2022 Apr 23;11(9):2371. doi: 10.3390/jcm11092371.